Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

June 30, 2008

Conditions
MetabolismFatty Liver
Interventions
DRUG

Somatropin and pegvisomant

Somatropin are given intravenous, 0.5mg pegvisomant are given subcutaneous, 15 mg NaCl are given subcutaneous, 2 ml

Trial Locations (1)

8000

Medical department M, Arhus Sygehus, Region midtjylland, Aarhus

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

Pfizer

INDUSTRY

lead

University of Aarhus

OTHER

NCT00476879 - Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content | Biotech Hunter | Biotech Hunter